মাল্টা - ইংরেজি - Malta Medicines Authority

mcneil products limited - balsam peru 1.875 % (w/v), bismuth oxide 0.875 % (w/v), bismuth subgallate 2.25 % (w/v), zinc oxide 10.75 % (w/v) - ointment

আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - dexamethasone, polymyxin b sulfate, neomycin sulfate - eye drops suspension - %w/v - corticosteroids and antiinfectives in combination

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

dr. reddy's laboratories limited - isotretinoin (unii: eh28up18if) (isotretinoin - unii:eh28up18if) - isotretinoin 10 mg - severe recalcitrant nodular acne zenatane is indicated for the treatment of severe recalcitrant nodular acne. nodules are inflammatory lesions with a diameter of 5 mm or greater. the nodules may become suppurative or hemorrhagic. “severe,” by definition,2 means “many” as opposed to “few or several” nodules. because of significant adverse effects associated with its use, zenatane should be reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. in addition, zenatane is indicated only for those patients who are not pregnant, because zenatane can cause life threatening birth defects (see boxed contraindications and warnings ).  a single course of therapy for 15 to 20 weeks has been shown to result in complete and prolonged remission of disease in many patients.1,3,4 if a second course of therapy is needed, it should not be initiated until at least 8 weeks after completion of the first course, because experience has shown that patients may

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

wockhardt limited - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 100 mg - bupropion hydrochloride extended-release tablets (sr) are indicated for the treatment of major depressive disorder. the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled trials of depressed inpatients and in one 6-week controlled trial of depressed outpatients whose diagnoses corresponded most closely to the major depression category of the apa diagnostic and statistical manual (dsm) (see clinical pharmacology). a major depressive episode (dsm-iv) implies the presence of 1) depressed mood or 2) loss of interest or pleasure; in addition, at least 5 of the following symptoms have been present during the same 2-week period and represent a change from previous functioning: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - dexamethasone; hypromellose; neomycin sulfate; polymyxin b sulfate - eye drops - 1mg/1ml ; 5mg/1ml ; 3500unit/1ml ; 6000unit/1ml

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - gabapentin - oral capsule - 100mg

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - gabapentin - oral capsule - 300mg

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - gabapentin - oral capsule - 400mg

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - gabapentin - oral tablet - 600mg

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - gabapentin - oral tablet - 800mg